Showing 12,781 - 12,800 results of 39,063 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 12781

    Testisin is required for barrier function in HMEC-1 endothelial monolayers. by Raymond J. Peroutka (8946971)

    Published 2020
    “…Mean ± SEM. ***: p<0.001, **: p<0.01, *: p<0.05, ns: not significant.…”
  2. 12782
  3. 12783

    Body weight development of male (upper curves) and female (lower curves) rats. by Matti Viluksela (321291)

    Published 2014
    “…Each data point represents mean ± SE (n = 5).</p>…”
  4. 12784
  5. 12785
  6. 12786

    NADPH oxidation and H<sub>2</sub>O<sub>2</sub> production by Bs3 and Bs3<sub>S211A</sub>. by Christina Krönauer (11301989)

    Published 2021
    “…<p>A) Buffer containing 100 μM NADPH was mixed with 0.2 μM Bs3 or Bs3<sub>S211A</sub> and incubated at 25°C. …”
  7. 12787

    BMD analysis of serum free T4 (A), serum free T3 (B) and serum TSH (C) in males (triangles) and females (circles). by Matti Viluksela (321291)

    Published 2014
    “…Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease or increase (CES -0.05) compared to background (a parameter). …”
  8. 12788

    BMD analysis of red cell count (A), hematocrit (B) and hemoglobin (C) in males (triangles) and females (circles). by Matti Viluksela (321291)

    Published 2014
    “…<p>These parameters were dose-dependently decreased in both genders. Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease (CES -0.05) compared to background (a parameter). …”
  9. 12789

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  10. 12790

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  11. 12791

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  12. 12792

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  13. 12793

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  14. 12794

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  15. 12795

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  16. 12796

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  17. 12797

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  18. 12798

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  19. 12799

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
  20. 12800

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”